Approval · Notice of Compliance 10607 · 2009

JANUMET: Notice of Compliance 10607

Issued September 24, 2009

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 10607
Date: September 24, 2009
Company: Merck Frosst Canada Ltd., Merck Frosst Canada Ltée
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Other
Therapeutic class: Oral Antihyperglycemic Agent; DPP-4 inhibitor; Incretin Enhancer

Products in this notice

Brand	DIN	Status today
JANUMET	02333856	Marketed
JANUMET	02333864	Cancelled Post Market
JANUMET	02333872	Marketed

Medicinal ingredients

METFORMIN HYDROCHLORIDE 500 MG per TAB
SITAGLIPTIN 50 MG per TAB
METFORMIN HYDROCHLORIDE 850 MG per TAB
METFORMIN HYDROCHLORIDE 1,000 MG per TAB